Literature DB >> 15203919

Immunological aspects of polymer microsphere vaccine delivery systems.

J E Eyles1, Z C Carpenter, H O Alpar, E D Williamson.   

Abstract

In vitro studies using dendritic cells have identified that microencapsulated antigens are taken up and processed differently as compared with soluble proteins, and these findings have been reviewed. Similarly, in vivo, it is evident that microencapsulated materials have different properties in terms of uptake and trafficking. Intranasal (IN) instillation of encapsulated protective antigen resulted in a significant increase in the percentage of activated CD4+ and B-cells in the spleens of immunised mice, whereas IN instillation of soluble antigen failed to do so. This corroborates earlier findings concerning the uptake and trafficking of microparticles following bronchopulmonary administration. These data support the tenet that microencapsulation serves to modify the uptake, trafficking and processing of antigens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15203919     DOI: 10.1080/10611860410001670017

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  10 in total

1.  Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.

Authors:  Angela M Arenas-Gamboa; Thomas A Ficht; Melissa M Kahl-McDonagh; Allison C Rice-Ficht
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

2.  Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Punit Bhatnagar; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

3.  Effect of particle size of nanospheres and microspheres on the cellular-association and cytotoxicity of paclitaxel in 4T1 cells.

Authors:  Sinjan De; Donald W Miller; Dennis H Robinson
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

4.  PLGA-polymer encapsulating tumor antigen and CpG DNA administered into the tumor microenvironment elicits a systemic antigen-specific IFN-γ response and enhances survival.

Authors:  Kevin P Nikitczuk; Rene S Schloss; Martin L Yarmush; Edmund C Lattime
Journal:  J Cancer Ther       Date:  2013-01-01

5.  Adjuvant properties of a biocompatible thermo-responsive polymer of N-isopropylacrylamide in autoimmunity and arthritis.

Authors:  Akhilesh Kumar Shakya; Ashok Kumar; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2011-05-04       Impact factor: 4.118

6.  The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.

Authors:  A M Arenas-Gamboa; T A Ficht; M M Kahl-McDonagh; G Gomez; A C Rice-Ficht
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

7.  Lipid nanoparticles as delivery vehicles for the Parietaria judaica major allergen Par j 2.

Authors:  Maria Luisa Bondì; Giovanna Montana; Emanuela Fabiola Craparo; Roberto Di Gesù; Gaetano Giammona; Angela Bonura; Paolo Colombo
Journal:  Int J Nanomedicine       Date:  2011-11-21

8.  Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection.

Authors:  Majela González-Miró; Laura M Rodríguez-Noda; Mildrey Fariñas-Medina; Barbara Cedré-Marrero; Sandra Madariaga-Zarza; Caridad Zayas-Vignier; Mabel Hernández-Cedeño; Torsten Kleffmann; Dagmar García-Rivera; Vicente Vérez-Bencomo; Bernd H A Rehm
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

9.  Polyacrylate-Peptide Antigen Conjugate as a Single-Dose Oral Vaccine against Group A Streptococcus.

Authors:  Mohammad Omer Faruck; Lili Zhao; Waleed M Hussein; Zeinab G Khalil; Robert J Capon; Mariusz Skwarczynski; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2020-01-13

Review 10.  Targeting the porcine immune system--particulate vaccines in the 21st century.

Authors:  Kenneth C McCullough; Artur Summerfield
Journal:  Dev Comp Immunol       Date:  2008-09-02       Impact factor: 3.636

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.